Man Group plc - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$703,000
-61.2%
195,340
-71.1%
0.00%
-57.1%
Q2 2019$1,814,000
-9.5%
676,959
-0.1%
0.01%
-12.5%
Q1 2019$2,005,000
-12.3%
677,459
-52.9%
0.01%
-20.0%
Q4 2018$2,287,000
-58.3%
1,438,113
-3.6%
0.01%
-50.0%
Q3 2018$5,490,000
+30.0%
1,491,764
-0.0%
0.02%
+17.6%
Q2 2018$4,223,000
-26.8%
1,492,264
-4.1%
0.02%
-34.6%
Q1 2018$5,773,0001,556,1640.03%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders